EPIVIR-HBV
LOE ApproachingNDAORALTABLETPriority Review
Approved
Dec 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EPIVIR-HBV is an oral small-molecule nucleoside reverse transcriptase inhibitor (NRTI) approved by GSK for the treatment of chronic hepatitis B virus (HBV) infection. The drug works by inhibiting HBV reverse transcriptase, reducing viral replication and improving liver function in infected patients. It represents a foundational antiviral therapy in the hepatitis B treatment landscape.
LOE Approaching
As a 26-year-old product approaching loss of exclusivity, this brand faces declining market share and is likely operating with a lean commercial team focused on managed care and market defense.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
EPIVIR-HBV is not actively linked to open job postings (0 openings identified), reflecting its late-stage lifecycle. Roles associated with this product are primarily focused on defending market share, managing payer relationships, and optimizing pricing in a generics-dominated environment rather than growth initiatives.
Brand ManagerField Sales Representative
Worked on EPIVIR-HBV at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.